Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in Recap

Chest - United States
doi 10.1016/j.chest.2016.08.551
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis and More Advanced Lung Function Impairment

Respiratory Medicine
PulmonaryRespiratory Medicine
2019English

M27 Effect of Pirfenidone on Breathlessness as Measured by the Ucsd-Sobq Score in Patients With Idiopathic Pulmonary Fibrosis (Ipf) With Moderate Lung Function Impairment

2017English

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2016English

Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis

Internal Medicine
Internal MedicineMedicine
2013English

P136 Factors Influencing Mortality in IPF Patients Treated With Pirfenidone

Thorax
PulmonaryRespiratory Medicine
2012English

Pirfenidone Should Be Prescribed for Patients With Idiopathic Pulmonary Fibrosis: Table 1

Thorax
PulmonaryRespiratory Medicine
2013English

Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Comparison of the Antifibrotic Effects of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-drug Pirfenidone in Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis

PLoS ONE
Multidisciplinary
2018English

A 2-Year Observational Study in Patients Suffering From Idiopathic Pulmonary Fibrosis and Treated With Pirfenidone: A French Ancillary Study of PASSPORT

Respiration
PulmonaryRespiratory Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy